Aug 2026· Digestive Diseases and Sciences· Vol 71, pp. 6064 - 6099· 0 citations· 99 references
Medicine
TL;DR
The findings suggest that traditional Chinese medicine, acupuncture, and dietary interventions can provide sustained relief from core symptoms of IBS-D, including diarrhea and abdominal pain.
Abstract
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common disorder of gut–brain interaction. Current therapeutic approaches frequently fail to provide sustained symptom relief. In recent years, complementary and alternative therapies—particularly traditional Chinese medicine, acupuncture, and dietary interventions—have attracted increasing attention due to their low side-effect profiles and are gradually becoming important adjunct strategies in the management of IBS-D. This review systematically summarizes the research advances of the past decade across these three therapeutic categories for IBS-D with a focus on their clinical efficacy and underlying mechanisms. The findings suggest that traditional Chinese medicine, acupuncture, and dietary interventions can provide sustained relief from core symptoms of IBS-D, including diarrhea and abdominal pain. Their therapeutic effects are mediated through multiple mechanisms, including modulation of the gut microbiota and its metabolites, restoration of intestinal mucosal barrier integrity, attenuation of visceral hypersensitivity, and regulation of the gut–brain axis. These therapies exhibit multi-target and systemic effects with a low incidence of adverse events, highlighting their promising clinical potential. They offer feasible strategies for achieving long-term remission and facilitating personalized management of IBS-D.
This paper provides a comprehensive review of the current state of knowledge on irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders, currently classified as a disorder of gut–brain interaction (DGBI). The review discusses the epidemiology, pathophysiology, clinical presentation, diagnostic...
Marlena Radzka, Izabela Radzka, Paweł Budzik et al.· International Journal of Inn...· 0 citations
Traditional treatments such as dietary fiber, probiotics, antispasmodics, laxatives, laxatives, prokinetics, antidepressants, antibiotics, and antihistamines are reviewed, emphasizing the limited and often inconsistent evidence supporting their use for pain relief and overall symptom improvement.
M. G. Puoti, A. Oorthuys, N. K. Vermeijden et al.· Drugs· 0 citations
Berberine combined with brain-gut axis-targeted medications shows promising efficacy and acceptable safety in the treatment of IBS-D, however, existing studies are limited by small sample sizes and methodological weaknesses, and the overall strength of evidence remains insufficient.
Nan-Xi Liu, Ya-Hui Huang, Hui-Xia Qiao et al.· Frontiers in Pharmacology· 0 citations
The results indicate that gut microbiota dysbiosis drives IBS symptoms through three major metabolic pathways - short-chain fatty acids, bile acids, and 5-hydroxytryptamine - and achieves bidirectional regulation via the GBA.
An-Ping Yu, Yan-Ru Bi, Xiao Xu· The American Journal of Chin...· 0 citations
Background: Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction characterized by recurrent abdominal pain and altered bowel habits, including constipation, diarrhea, or both. Its multifactorial pathophysiology and substantial impact on quality of life necessitate individualized, multidisciplina...
Abeer Faiz Alanzi, Hanan Shaybub Jarallah Alfaleh, I. Al-Humam et al.· Saudi Journal of Medicine an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.